Format
Sort by
Items per page

Send to

Choose Destination

Best matches for anti-CD20 antibody synthesis:

Search results

Items: 1 to 20 of 762

1.

The B cell death function of obinutuzumab-HDEL produced in plant (Nicotiana benthamiana L.) is equivalent to obinutuzumab produced in CHO cells.

Lee JW, Heo W, Lee J, Jin N, Yoon SM, Park KY, Kim EY, Kim WT, Kim JY.

PLoS One. 2018 Jan 11;13(1):e0191075. doi: 10.1371/journal.pone.0191075. eCollection 2018. Erratum in: PLoS One. 2018 Apr 11;13(4):e0195917.

2.

An improved method to quantify human NK cell-mediated antibody-dependent cell-mediated cytotoxicity (ADCC) per IgG FcR-positive NK cell without purification of NK cells.

Sung AP, Tang JJ, Guglielmo MJ, Redelman D, Smith-Gagen J, Bateman L, Hudig D.

J Immunol Methods. 2018 Jan;452:63-72. doi: 10.1016/j.jim.2017.11.002. Epub 2017 Nov 4.

PMID:
29113954
3.

A Versatile Chemo-Enzymatic Conjugation Approach Yields Homogeneous and Highly Potent Antibody-Drug Conjugates.

Xu Y, Jin S, Zhao W, Liu W, Ding D, Zhou J, Chen S.

Int J Mol Sci. 2017 Oct 31;18(11). pii: E2284. doi: 10.3390/ijms18112284.

4.

Transient BAFF Blockade Inhibits Type 1 Diabetes Development in Nonobese Diabetic Mice by Enriching Immunoregulatory B Lymphocytes Sensitive to Deletion by Anti-CD20 Cotherapy.

Wang Q, Racine JJ, Ratiu JJ, Wang S, Ettinger R, Wasserfall C, Atkinson MA, Serreze DV.

J Immunol. 2017 Dec 1;199(11):3757-3770. doi: 10.4049/jimmunol.1700822. Epub 2017 Oct 20.

PMID:
29055002
5.

Primary mediastinal large B-cell lymphoma: Outcome of a series of pediatric patients treated with high-dose methotrexate and cytarabine plus anti-CD20.

Pillon M, Carraro E, Mussolin L, Conter V, Tondo A, Aricò M, Mura R, Sala A, Vinti L, Buffardi S, Pierani P, d'Amore ESG, Basso G.

Pediatr Blood Cancer. 2018 Feb;65(2). doi: 10.1002/pbc.26855. Epub 2017 Oct 19.

PMID:
29049862
6.

The ABCs of Immunotherapy for Adult Patients With B-Cell Acute Lymphoblastic Leukemia.

Horvat TZ, Seddon AN, Ogunniyi A, King AC, Buie LW, Daley RJ.

Ann Pharmacother. 2018 Mar;52(3):268-276. doi: 10.1177/1060028017736539. Epub 2017 Oct 12.

PMID:
29025266
7.

Tumor-associated B-cells induce tumor heterogeneity and therapy resistance.

Somasundaram R, Zhang G, Fukunaga-Kalabis M, Perego M, Krepler C, Xu X, Wagner C, Hristova D, Zhang J, Tian T, Wei Z, Liu Q, Garg K, Griss J, Hards R, Maurer M, Hafner C, Mayerhöfer M, Karanikas G, Jalili A, Bauer-Pohl V, Weihsengruber F, Rappersberger K, Koller J, Lang R, Hudgens C, Chen G, Tetzlaff M, Wu L, Frederick DT, Scolyer RA, Long GV, Damle M, Ellingsworth C, Grinman L, Choi H, Gavin BJ, Dunagin M, Raj A, Scholler N, Gross L, Beqiri M, Bennett K, Watson I, Schaider H, Davies MA, Wargo J, Czerniecki BJ, Schuchter L, Herlyn D, Flaherty K, Herlyn M, Wagner SN.

Nat Commun. 2017 Sep 19;8(1):607. doi: 10.1038/s41467-017-00452-4.

8.

HDAC6 inhibition upregulates CD20 levels and increases the efficacy of anti-CD20 monoclonal antibodies.

Bobrowicz M, Dwojak M, Pyrzynska B, Stachura J, Muchowicz A, Berthel E, Dalla-Venezia N, Kozikowski M, Siernicka M, Miazek N, Zapala P, Domagala A, Bojarczuk K, Malenda A, Barankiewicz J, Graczyk-Jarzynka A, Zagozdzon A, Gabrysiak M, Diaz JJ, Karp M, Lech-Maranda E, Firczuk M, Giannopoulos K, Efremov DG, Laurenti L, Baatout D, Frenzel L, Malinowska A, Slabicki M, Zenz T, Zerrouqi A, Golab J, Winiarska M.

Blood. 2017 Oct 5;130(14):1628-1638. doi: 10.1182/blood-2016-08-736066. Epub 2017 Aug 22.

PMID:
28830887
9.

The Antitumor Activity of IMGN529, a CD37-Targeting Antibody-Drug Conjugate, Is Potentiated by Rituximab in Non-Hodgkin Lymphoma Models.

Hicks SW, Lai KC, Gavrilescu LC, Yi Y, Sikka S, Shah P, Kelly ME, Lee J, Lanieri L, Ponte JF, Sloss CM, Romanelli A.

Neoplasia. 2017 Sep;19(9):661-671. doi: 10.1016/j.neo.2017.06.001. Epub 2017 Jul 25.

10.

Applying near-infrared photoimmunotherapy to B-cell lymphoma: comparative evaluation with radioimmunotherapy in tumor xenografts.

Heryanto YD, Hanaoka H, Nakajima T, Yamaguchi A, Tsushima Y.

Ann Nucl Med. 2017 Nov;31(9):669-677. doi: 10.1007/s12149-017-1197-9. Epub 2017 Jul 24.

11.

Assessment of T- and B-lymphocytes and VEGF-A in acute pancreatitis.

Căluianu EI, Alexandru DO, Târtea EA, Georgescu M, MercuŢ D, Traşcă ET, Iancău M.

Rom J Morphol Embryol. 2017;58(2):481-486.

12.

Role for ZAP-70 Signaling in the Differential Effector Functions of Rituximab and Obinutuzumab (GA101) in Chronic Lymphocytic Leukemia B Cells.

Skopelja-Gardner S, Jones JD, Hamilton BJ, Danilov AV, Rigby WFC.

J Immunol. 2017 Aug 15;199(4):1275-1282. doi: 10.4049/jimmunol.1602105. Epub 2017 Jul 14.

PMID:
28710251
13.

Prevention of Human Lymphoproliferative Tumor Formation in Ovarian Cancer Patient-Derived Xenografts.

Butler KA, Hou X, Becker MA, Zanfagnin V, Enderica-Gonzalez S, Visscher D, Kalli KR, Tienchaianada P, Haluska P, Weroha SJ.

Neoplasia. 2017 Aug;19(8):628-636. doi: 10.1016/j.neo.2017.04.007. Epub 2017 Jun 26.

14.

Advantages of targeting B cell receptor complex to treat B-cell derived autoimmune diseases and lymphomas.

Adem J, Eray M, Eeva J, Nuutinen U, Pelkonen J.

Mol Immunol. 2017 Aug;88:135-137. doi: 10.1016/j.molimm.2017.05.023. Epub 2017 Jun 20.

PMID:
28644972
15.

Antibody-Dependent NK Cell Activation Differentially Targets EBV-Infected Cells in Lytic Cycle and Bystander B Lymphocytes Bound to Viral Antigen-Containing Particles.

López-Montañés M, Alari-Pahissa E, Sintes J, Martínez-Rodríguez JE, Muntasell A, López-Botet M.

J Immunol. 2017 Jul 15;199(2):656-665. doi: 10.4049/jimmunol.1601574. Epub 2017 Jun 19.

PMID:
28630095
16.

Papillary thyroid carcinoma expressing CD20.

Sasaki Y, Seto M, Miyoshi H, Okada S, Yokoyama S, Ohshima A, Ohshima K.

Pathol Int. 2017 Jul;67(7):350-354. doi: 10.1111/pin.12548. Epub 2017 Jun 15.

PMID:
28618063
17.

Humanization of chimeric anti-CD20 antibody by logical and bioinformatics approach with retention of biological activity.

Khoo YL, Cheah SH, Chong H.

Immunotherapy. 2017 Jun;9(7):567-577. doi: 10.2217/imt-2017-0016.

PMID:
28595518
18.

Chronic lymphocytic leukemia: pathophysiology and current therapy.

Takizawa J.

Rinsho Ketsueki. 2017;58(5):471-479. doi: 10.11406/rinketsu.58.471. Japanese.

PMID:
28592762
19.

B cells do not have a major pathophysiologic role in acute ischemic stroke in mice.

Schuhmann MK, Langhauser F, Kraft P, Kleinschnitz C.

J Neuroinflammation. 2017 Jun 2;14(1):112. doi: 10.1186/s12974-017-0890-x.

20.

STING Activation Reverses Lymphoma-Mediated Resistance to Antibody Immunotherapy.

Dahal LN, Dou L, Hussain K, Liu R, Earley A, Cox KL, Murinello S, Tracy I, Forconi F, Steele AJ, Duriez PJ, Gomez-Nicola D, Teeling JL, Glennie MJ, Cragg MS, Beers SA.

Cancer Res. 2017 Jul 1;77(13):3619-3631. doi: 10.1158/0008-5472.CAN-16-2784. Epub 2017 May 16.

Supplemental Content

Loading ...
Support Center